peter-deyoung

Leadership Message

“At Piramal Pharma, our supply chain is more than an operational function, it is a critical enabler of our purpose to improve the well-being of patients and consumers worldwide.

We serve global markets with a shared commitment to quality, integrity, sustainability, and operational excellence. While each of our business operates within its own supply ecosystem, all suppliers are governed by a common set of Piramal Pharma standards and expectations.

As global supply chains evolve, we continue to strengthen collaboration with our partners to build a future-ready, ethical, resilient, and sustainable value chain.”

Peter DeYoung

CEO, Global Pharma

Our Strategic Priorities

strategic-priorities

Our supply chain strategy supports business growth, customer success, and long-term sustainability.

sp-101

Reliable Supply

Ensuring uninterrupted product availability across global markets.

sp-202

Quality & Compliance

Meeting the highest standards of regulatory compliance and product quality.

sp-303

Supplier Collaboration

Building strong partnerships that drive innovation and continuous improvement.

sp-404

Digital Procurement

Leveraging technology and data to enhance efficiency and transparency.

sp-505

Sustainable Value Chains

Reducing environmental impact and advancing responsible sourcing practices.

sp-606

Risk & Resilience

Strengthening supply continuity through proactive risk management and business continuity planning.

What We Expect From Our Suppliers

  • os-1

    Quality & Compliance

    Maintain robust quality systems, regulatory compliance, and audit readiness while proactively communicating material changes.

  • os-2

    Supply Reliability

    Deliver products and services consistently, on time, and in full, while maintaining transparent communication regarding potential disruptions.

  • os-3

    Regulatory Excellence

    Provide accurate documentation, maintain applicable certifications (cGxP, ICH, ISO 9001/14001/45001, GMP, FDA, etc), and support regulatory inspections and audits.

  • os-4

    Responsible Sourcing

    Operate ethically, transparently, and sustainably, uphold human rights, prevent forced or child labour, and comply with our Supplier Code of Conduct and Sustainable Procurement Policy.

  • os-5

    Risk Resilience

    Maintain business continuity plans, identify critical risks, and collaborate on supply chain resilience initiatives.

  • os-6

    Ethics & Integrity

    Demonstrate the highest standards of ethical conduct, Uphold zero tolerance for bribery and corruption, data privacy protection, and transparent reporting.

our-suppliers

Visit Piramal Pharma Solutions Supply Chain page for additional requirements and category-specific guidance on our CDMO business.

Our Sustainability Commitments

Sustainability is embedded across our supply chain strategy.

42% reduction in Scope 1 and Scope 2 emissions by FY2030 (FY2022 baseline)

25% reduction in Scope 3 emissions by FY2030 (FY2022 baseline)

Science Based Targets initiative (SBTi)-validated emission reduction targets

Active Full Member of the Pharmaceutical Supply Chain Initiative (PSCI)

Reporting aligned with EcoVadis, PSCI, BRSR, CDP, GRI, S&P Global, UNGC, M2030

Compliance with Canada's Bill S-211 on forced and child labour in supply chains

Partnering For Impact

partnering-1

Measure and disclose greenhouse gas emissions

partnering-2

Adopt science-based climate targets

partnering-3

Strengthen ESG governance and reporting

partnering-4

Embed sustainability practices throughout their operations

Supplier Development & Collaboration

We view suppliers as strategic partners in delivering quality, innovation, and sustainable growth.

sdc

Our supplier development programs include:

  • Quality, regulatory, and ESG capability-building workshops
  • Supplier performance reviews and improvement plans
  • Innovation partnerships for new materials and sustainable solutions
  • Digital collaboration through sourcing and supplier management platforms
  • Partner with suppliers on LCA and PCF studies to identify carbon reduction opportunities.

We value partners who share our commitment to continuous improvement, transparency, and long-term collaboration.

Supplier Sustainability Progress

ssp-1
100%

Suppliers governed by Supplier Code of Conduct

ssp-2
170+

Supplier assessments completed, including >50% of critical suppliers

ssp-3
180+

Participants trained on Sustainability across 120+ global suppliers

Become A Piramal Pharma Supplier

We welcome partnerships across a broad range of categories

Active pharmaceutical ingredients (APIs), intermediates, and excipients

Contract manufacturing and analytical services

Specialty raw materials and nutraceutical ingredients

LCA & PCF-Enabled Material Supplier

Sustainable packaging innovations across primary and secondary formats

Capital equipment, MRO, and indirect procurement

Interested In Partnering With Us?

FAQ

How do I become a Piramal Pharma supplier?

Submit your company profile through our Supplier Expression of Interest portal. Shortlisted suppliers are invited for qualification and onboarding.

Which business units does Piramal source for?

We source for all three businesses PPS (CDMO), PCC (critical care), and PCH (consumer healthcare) under one unified group governance framework.

Does Piramal accept third-party sustainability assessments?

Yes. We recognise EcoVadis, PSCI, Sedex, CDP, and DJSI assessments to reduce audit duplication for our suppliers.

What are Piramal's expectations on ESG and SBTi alignment?

Suppliers are expected to disclose ESG metrics, report emissions data, and progressively align with science-based targets. Detailed expectations are set out in our Supplier Sustainability Guidelines.

How are supplier audits conducted?

Audits are conducted based on supplier risk profiles typically annually to once every three years - through self-assessments, on-site audits, and PSCI assessments.

Whom should I contact for queries?

Fill out this form for any questions – Contact Us

External Standards & References

Piramal Pharma aligns its supply chain practices with global benchmarks including The GHG Protocol, Science-Based Targets initiative (SBTi), UN Sustainable Development Goals (SDGs), PSCI Principles, and Applicable global regulatory authority guidelines.